New Agonists of the Incretin/Glucagon System for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis

Gastroenterology. 2024 Nov 30:S0016-5085(24)05755-X. doi: 10.1053/j.gastro.2024.11.016. Online ahead of print.
No abstract available